SHEEL — Sheel Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.59bn
- IN₹1.76bn
- IN₹1.02bn
- 32
- 49
- 66
- 47
Annual cashflow statement for Sheel Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 45.9 | 63.7 | 123 | 128 |
| Depreciation | ||||
| Non-Cash Items | 11.1 | 15.1 | 14.9 | 12.8 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -44.5 | 3.96 | -157 | -57.9 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 21.9 | 92.9 | -9.2 | 92.1 |
| Capital Expenditures | -12.1 | -11.5 | -2.94 | -12.4 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -9.06 | -10.2 | 0.424 | -10.1 |
| Sale of Fixed Assets | ||||
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -21.2 | -21.8 | -2.52 | -22.5 |
| Financing Cash Flow Items | -24.6 | -28.1 | -28.1 | -29.4 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -2.26 | -72.2 | 15.6 | -71 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -1.51 | -1 | 3.92 | -1.39 |